Jump to content

Anticalin

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 172.129.133.83 (talk) at 16:08, 16 July 2007. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Anticalin is a new generation of therapeutic protein products, synthesized from human lipocalins which are a family of naturally binding proteins. Anticalins are being used in lieu of monoclonal antibodies, the physicochemical properties being the same except for differences in their molecular weight, the former having a size of about 20kDa.